MAPT and Alzheimer disease: The translation and clinical Aβ, tau, and FDG PET imaging have transformed our understanding of AD (Scheltens et al., 2021), generated new insights (Aschenbrenner et al., 2018), and opened an avenue for the early detection of AD (Frisoni et al., 2017).